RNA Technologies Enabling Drug Discovery and Development

RNA Technologies Enabling Drug Discovery and Development

This research service encompasses a comprehensive analysis of RNA therapy industry from the following perspectives:
• Industry Drivers and Challenges
• Technology Snapshot and Trends
• Clinical Pipeline Analysis
• Overview of the IP Landscape
• Innovator Profiles
• Future Roadmap
The RNA therapy platforms covered include:
• Splice-Switching Oligonucletides (SSO)
• Other Anti-Sense Oligonucleotide (ASO)
• Aptamers
• RNA-interference
• mRNA
• saRNA
An appendix is included, comprising lists of major industry influencers found in the study.

  • Executive Summary
    • Research Scope: RNA Therapies Redefining the Healthcare Landscape
    • Analysis Framework: Frost & Sullivan's Core Value
    • Research Methodology: Five Steps Towards Success
    • Key Findings
  • RNA Therapies: Industry Overview
    • RNA is the Rising Star of Transformative Therapy Platforms
    • Industry Accelerators and Challenges
    • RNA Delivery: Technology Segmentation
    • RNA Therapies: Technology Segmentation
    • Molecular Insights Across RNA Therapy
  • Technology Trends & Clinical Pipeline
    • Alternative Splicing Induced by SSO Therapies
    • Clinical Pipeline Analysis for SSO Therapies for SMA and DMD
    • Post-transcriptional Modifications by ASO
    • Clinical Pipeline Overview for ASO Therapies
    • Emerging Clinical Pipeline for ASO Therapies
    • Early Phase ASO Therapies
    • Inhibition of Ligand Binding by Aptamer
    • Clinical Pipeline Analysis for Aptamer Therapies
    • Landmark Year for RNA Interference Therapy Platform
    • Clinical Analysis of RNA Interference Therapeutics
    • Overview of the Emerging Landscape for mRNA Therapies
    • Clinical Pipeline Analysis of mRNA Therapies
    • saRNA: The Rising Participant in RNA-based Therapies
  • Overview of The Patent Landscape
    • Patenting Trends for ASO Technologies
    • Patenting Trends for RNAi Platforms
    • Patenting Trends for mRNA Technologies
  • Innovation Profiles
    • Targeted RNAi Technology for Enhanced Disease Management
    • Enabling Targeted Delivery of RNAi Therapeutics
    • Developing Stable and Non-immunogenic mRNA Therapies
    • Fueling Novel RNA Therapy and Delivery Platforms
    • Enabling Potent Antisense Therapeutics
  • Future Perspectives
    • RNA Platforms likely to Transform the Future of Health & Wellness
    • Navigating Through The Future Landscape for RNA Technologies
  • Growth Opportunities and Companies to Action
    • Growth Opportunity 1: ASO Therapies
    • Growth Opportunity 2: RNAi Therapies
    • Growth Opportunity 3: mRNA Therapies
    • Strategic Imperatives for Success and Growth
  • Key Industry Influencers
    • Industry Interactions

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings